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Abstract 
Proteins secreted by cancer cells are a major component of tumor microenvironment. However, 
little is known on the impact of single oncogenic lesions on the expression of secreted proteins at 
early stages of tumor development. Because c-Myc over-expression is among the most frequent 
alterations in cancer, here we investigated the effect of sustained c-Myc expression on the 
secretome of a non-transformed human epithelial cell line (hT-RPE). By using a quantitative 
proteomic approach we have identified 125 proteins in conditioned media of hT-RPE/MycER 
cells upon c-Myc induction. Analysis of the 49 proteins significantly down-regulated by c-Myc, 
revealed a marked enrichment of factors associated with growth inhibition and cellular 
senescence. Accordingly, media conditioned by hT-RPE cells expressing c-Myc show an 
increased ability to sustain hT-RPE cellular proliferation/viability. We also find a marked down-
regulation of several structural and regulatory components of the extracellular matrix (ECM), 
which correlates with an increased chemotactic potency of the conditioned media towards 
fibroblasts, a major cellular component of tumor stroma. In accordance with these data, the 
expression of the majority of the genes encoding proteins down-regulated in hT-RPE was 
significantly reduced also in colorectal adenomatous polyps, early tumors in which c-Myc is 
invariably over-expressed. These findings help to elucidate the significance of c-Myc over-
expression at early stages of tumor development and uncover a remarkable autocrine/paracrine 
component in the ability of c-Myc to stimulate proliferation, sustain tumor maintenance and 
modulate cell migration. 
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Introduction 
Tumor initiation and progression is a complex process where normal epithelial cells acquire a 
series of novel capabilities that change their behavior in the context of the tissue architecture and 
drive the formation of a new tissue entity: the tumor mass. The evolution of this transformation 
process is strictly dependent on the cellular microenvironment where it takes place and can be 
controlled by cell-to-cell communications of the transforming epithelial cells with the 
surrounding cellular components of the stroma, particularly fibroblasts, endothelial cells, 
macrophages and other components of the immune system1. Cellular communication is achieved 
by the ability of cells to secrete specific factors and express specific receptors on the membrane. 
Secreted factors can have a strong influence on tumor initiation and progression because they can 
mediate multiple cell-to-cell communications. They can act in an autocrine fashion by positively 
or negatively influencing the ability of the tumor cells to survive and/or proliferate. They can 
also act in a paracrine fashion by influencing the behavior of the surrounding cellular 
components of the stroma2. 
Autocrine production of growth and survival factors from cancer cells has long been regarded as 
a mechanism to uncouple cell growth and proliferation from the extracellular context3. 
Oncogenes like ras or raf are known to increase the production of the growth and survival 
factors, resulting in a reduced dependency on the microenvironment for growth and survival4. On 
the other hand, factors secreted by oncogenically transformed cells have been shown to mediate 
opposite effects on cellular physiology. Increased production of IGFBP7, for instance, has been 
suggested to play a major role in the induction of cellular senescence in melanocytes acquiring 
activating mutations in either BRAF or Ras5. Similarly, secreted factors like TGFβ and the 
inhibitors of the Wnt pathway, SRFP and DKK, are known to transduce intracellular anti-
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 5 
proliferative signals and have been associated with cellular senescence6,7. A recent review has 
proposed to group the secreted factors associated to cellular senescence under the collective 
name of Senescence Messaging Secretome (SMS)8. 
Therefore, understanding how the pool of factors secreted by epithelial cells is influenced by the 
acquisition of oncogenic lesions, like the activation of oncogenes or the inactivation of tumor 
suppressor proteins, can be extremely useful to understand the process of tumor initiation and 
progression.  
 
The transcription factor c-Myc is found over-expressed in many tumors, ranging from B-cell 
lymphoma to colon, breast carcinomas and melanomas9. A series of studies have shown that c-
Myc influences the expression of a high number of proteins involved in diverse cellular 
functions, like cell cycle regulation, apoptosis, metabolism, cell adhesion and cellular 
differentiation10. In most cases, however, the link between the function of c-Myc target genes and 
the ability of this proto-oncogene to contribute to cellular transformation remains elusive. 
Although c-Myc can display intrinsic tumor suppressing activity when expressed in primary 
cells11, c-Myc can be also required to counteract the intrinsic tumor suppressor activities of other 
oncogenes. In melanoma, for instance, continuous c-Myc expression is required to overcome 
cellular senescence induced by activating mutations in either BRAF or Ras12. In vivo, inhibition 
of c-Myc activity in Kras-induced tumors, using an inducible dominant negative protein, resulted 
in a marked shrinkage of the tumor, accompanied by a significant increase in expression of the 
Senescence-Associated β-Galactosidase13. c-Myc expression is therefore continuously required 
for tumor progression and maintenance. 
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Given the importance of c-Myc in so many aspects of cellular physiology and given the complex 
output resulting from c-Myc induction, a big effort has been put in the identification of c-Myc-
induced transcriptional14 and proteomic changes15-17. In these studies, the expression changes 
measured at the protein level were in good agreement with global RNA expression analyses 
confirming that c-Myc influences the expression of a high number of proteins involved in diverse 
cellular functions. Furthermore, proteomics is more effective in the analysis of specific sub-
cellular compartments, making it easier to detect changes directly relevant to cellular physiology 
compared to global studies. On this basis, the group of Aebersold has applied a quantitative 
proteomics approach to characterize c-Myc induced changes in the chromatin enriched16, soluble 
and mitochondrial fractions17 of Rat1 fibroblasts.  
To gain insights into the initial steps of oncogenic transformation, we have recently introduced 
MycER in a human epithelial cell line immortalized with the catalytic subunit of Telomerase (hT-
RPE). Using this system we found that c-Myc induced the down-regulation of the secreted 
protease urokinase. Interestingly, this correlated with changed chemotactic properties of culture 
media conditioned by cells with active c-Myc11. This suggests that c-Myc activation could 
influence the microenvironment of a developing tumor, by controlling the expression of secreted 
proteins acting either in an autocrine or a paracrine fashion. The relevance of paracrine effects of 
c-Myc activation was underlined also by the work of Dews et al., showing that c-Myc-mediated 
repression of the anti-angiogenic factors thrombospondin-1 and CTGF resulted in vigorous 
tumor vascularization and growth18. Furthermore, in SV-40 driven tumors, c-Myc has been 
shown to be necessary also for the maintenance of the tumor microenvironment19. But how and 
to what extent the cellular microenvironment is altered through the regulation of the expression 
of secreted proteins by c-Myc has not been addressed. Therefore, we aimed to investigate c-Myc 
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 7 
induced changes in the entire secretome using our non-transformed epithelial cells as model 
system. By using a quantitative proteomic approach based on stable isotope labeling, we found 
that c-Myc activation resulted in the down-modulation of proteins involved in cellular 
senescence as well as in regulatory and structural extracellular matrix components. 
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Materials and Methods 
 
Cell Culture 
hT-RPE/MycER cells were described previously11. hT-RPE/MycER cells, parental hT-RPE cells 
and Swiss-3T3 mouse fibroblasts were all cultured in Dulbecco's modified Eagle's medium 
supplemented with 100 µg/ml streptomycin, 100 units/ml penicillin, and 10% fetal bovine serum 
(FBS) (pH 7.2–7.4) in a humidified atmosphere containing 5% CO2 at 37 °C. 
 
Sample preparation 
hT-RPE/MycER cells were plated in 12 x 15 cm2 dishes (6 x 105 cells/dish) and grown 48 hours 
in the absence (6 dishes) or the presence (6 dishes) of 150 nM 4-hydroxytamoxifene (4-OHT) in 
DMEM supplemented with 10% FBS. Cells were washed 7 times with 13 ml of serum-free 
DMEM and grown for 24 hours in serum-free DMEM with or without 150 nM 4-OHT. 
Conditioned media (100 ml) were collected and centrifuged 10 min at 1500 rpm to remove cell 
debris. Samples were concentrated using centrifugal filters with a 10 kDa cut-off (Centricon 
Plus-70 and Microcon, Millipore) at 4 °C. Concentrated samples were resuspended in 50 mM 
Tris/HCl, 0.1 % SDS, pH 8.5. Protein concentrations were determined using Micro BCA Protein 
Assay Kit (Thermo Scientific) and 100 µg of each sample was used for the quantitative 
proteomic analysis. A total of two biological samples were prepared and analyzed. 
 
Cellular proliferation/viability assay 
Cellular proliferation/viability was assayed using a Cell-Titer-Glo® Luminescent Cell Viability 
Assay (Promega), that measures intracellular ATP level. Briefly, equal numbers of cells (4 x 103 
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 9 
cells/well) were seeded in white-walled 96 well plates and incubated in triplicate with 
conditioned media (50 µl/well) from hT-RPE/MycER cells grown either in presence or in 
absence of 4-OHT, as described below (sample preparation). After 48 hours, a volume of 50 µl of 
the reaction reagent was added to each well, and after 10 min, the luminescence signal was 
detected using a plate-reading luminometer (GloMax® 96 Luminometer, Promega). 
 
Chemotaxis assay 
Chemotaxis assays were performed in Boyden chambers by using 8 µm-pore-size PVPF-free 
filters (insert growth area 0.33 cm2) coated with collagen type VI 50 µg/ml O.N. at 4 °C, as 
previously described11. Briefly, following a 48 hours pre-incubation with or without 4-OHT in 
full serum medium, media conditioned by hT-RPE/MycER cells treated or not with 4-OHT for 
24 hours in serum free conditions were used as chemoattractants in the lower compartment of 
Boyden chambers. Swiss-3T3 mouse fibroblasts were detached by mild trypsinization, and 
inoculated into the upper compartment of Boyden chambers. After 2h of incubation at 37°C, the 
cells on the upper side of the membrane were removed by scraping and cells on the lower side of 
the filters were stained with Ematoxilin (Mayer’s) and counted. 
 
Western Blot Analysis 
Equal amounts of concentrated conditioned media were separated on a 10% SDS-PAGE and 
transferred to an Immobilon-P PVDF membrane (Millipore). The membrane was subsequently 
incubated for 2 h at room temperature in TBST buffer (125 mM Tris-HCl (pH 8.0), 625 mM 
NaCl, 0.1% Tween 20) containing 5% skim milk and further incubated with the primary 
antibodies. The immune complexes were detected using the ECL detection system, according to 
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the manufacturer’s protocol (Millipore). Mouse monoclonal antibody anti-IGFBP-7 (W18R), 
rabbit polyclonal antibody anti-IGFBP-6 (H-70) and goat polyclonal antibody anti-Cathepsin D 
(R-20) were from Santa Cruz Biotechnology. Goat polyclonal antibody anti-Dkk3 (ab2459), 
mouse monoclonal antibodies anti-TGFβ2 (Ab36495) and anti-GAPDH (Ab36495) were from 
Abcam. Mouse monoclonal antibody anti-vimentin (V 6630) and rabbit polyclonal antibody anti-
Actin were from Sigma. Rabbit polyclonal anti-uPA was a gift of P.A. Andreasen, Aarhus, 
Denmark. 
 
c-ICAT labeling and sample analysis 
1D PAGE cleavable ICAT (c-ICAT) procedure was performed using the c-ICAT reagent kit 
(Applied Biosystems) according to manufacturer’s protocol with minor modifications. The two 
biological replicates were analyzed separately. Briefly, for each biological sample100 µg of 
proteins were dissolved in 80 µl 50 mM Tris 0.1% SDS and reduced with 2 µl of 50 mM TCEP 
for 10 min at 100 °C. Samples from control and MycER activated cells were labeled respectively 
with the light and heavy reagents. Samples were combined, concentrated, loaded onto 1D-SDS 
PAGE (1.5 mm X 10 cm) and stained with Coomassie brilliant blue G-250. The gel lane was cut 
into 15 slices (3-mm each) washed and in-gel digested using trypsin at 6 ng/µL in 50 mM 
NH4HCO3 10% ACN for 16 hours. Peptides were extracted sequentially using 100 µl 30% ACN 
3.5% formic acid (HCOOH), 100 µl 50% ACN 5% HCOOH and 100 µl ACN, were combined 
and vacuum dried. Affinity chromatography by avidin cartridge was used to purify peptides. 
Labeled peptides were eluted in 30% ACN 0.4% TFA. The cleavable biotin group was removed 
by acid hydrolysis. 
Page 10 of 43
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 11 
Samples were analyzed by nano-HPLC-ESI-MS/MS using the QSTAR Elite (Applied 
Biosystems, Foster City, CA, USA) equipped with a nanoflow electrospray ion source. Pulled 
silica capillary (170 µm OD/100 µm ID, tip 30 µm ID) was used as nanoflow tip. The samples 
(20 µL) were loaded, purified and concentrated on a trap column PepMap, C18, 5 mm length, 
300 Å, (LCPackings, Sunnyvale, CA, USA) at 30 µL/min flow rate. Peptide separation was 
performed by Ultimate 3000 (Dionex, Sunnyvale, CA USA) using a capillary column, PepMap, 
C18, 15 cm length, 75 µm ID, 300 Å (LCPackings, Sunnyvale, CA USA), solvent A: 2% ACN in 
0.1% HCOOH and solvent B: 98% ACN in 0.1% HCOOH at 300 nL/min flow rate. The 
following gradient was used: 5-50% B in 60 min, 50-98% B in 6 sec. CID experiments were 
carried out in IDA mode using nitrogen as collision gas. Two independent nano-HPLC-ESI-
MS/MS experiments were performed for each sample. 
 
Database search 
Tandem mass spectra were extracted and peak lists were generated by Analyst QS 2.0 software 
using the default parameters. Peak lists containing all acquired MS/MS spectra were analyzed 
using Mascot Server (version 2.2) and X! Tandem (www.thegpm.org; version 2007.01.01.1). 
Mascot Server was set up to search the SwissProt 2010_09 Human database containing 20359 
entries. Trypsin was specified as the digestion enzyme with a maximum of one missed cleavage 
site. X! Tandem was set up to search the same database. Mascot and X! Tandem were run with a 
fragment ion mass tolerance of 0.08 Da and a parent ion tolerance of 50 ppm. Alkylation of 
cysteine with 12C (light) c-ICAT and with 13C (heavy) c-ICAT and oxidation of methionine were 
set as variable modification in Mascot and X! Tandem searches.  
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Criteria for protein identification 
Scaffold (version Scaffold_2_04_00, Proteome Software Inc., Portland, OR) was used to validate 
MS/MS based peptide and protein identifications. Protein probabilities were assigned by the 
Protein Prophet algorithm20. Protein identifications were accepted if they had greater than 99.0% 
probability and contained at least 2 unique identified peptides, unless otherwise mentioned. For 
proteins identified on the basis of one unique peptide the following criteria were used: i) 
identification in both ICAT experiments, ii) Mascot MS/MS ion score greater than 25 at 
significance threshold p<0.05 (95% confidence), iii) at least three consecutive peptide fragments 
identified in the MS/MS spectrum and (iv) ICAT ratio changes beyond 33% of the population 
median. The latter criterion was used in order to include only proteins having considerably 
changed expression upon cMyc induction. An analysis of false-positive rate of the protein 
identifications was performed by searching all tandem mass spectra from the nano-HPLC-ESI-
MS/MS analyses of the c-ICAT peptide fractions against an in-house curated decoy SwissProt 
human protein database containing forward and reversed sequences. In addition, contaminants 
such as human keratins and porcine trypsin etc. were included in this database. The false-positive 
rate analysis resulted in the identification of 11 unique peptides from the decoy database as 
compared with 695 peptides from the target database. False discovery rate was calculated by 
computing the ratio of these two values21. Based on this calculation we estimate a percentage of 
false-positives 1.58% for the present c-ICAT peptide data set. 
 
Quantification and Bioinformatics Analysis 
All spectra (Analyst wiff file) and MASCOT-based sequence assignments were imported into the 
MSQuant 2.0a81software22 for protein quantitation. MSQuant calculated the intensity ratios of 
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each of the heavy (H) and light (L) peptide pairs (ratio=Intensity H/Intensity L). The overall 
mean and variance for each peptide was determined from all observations of a given peptide at a 
specific time point. Final protein quantitation rations were calculated in each biological sample 
as the average H/L ratios of the peptides constituting the protein. All assignments made for 
quantitation were displayed and manually validated. Global median normalization method was 
used to correct for unequal mixing, labeling and for the error in the initial protein concentrations. 
Corrected protein ratios of the two experiments were log2 transformed and graphed on a scatter 
plot to visualize the biological reproducibility. Non-linear (Gaussian) regression analysis was 
performed using the GraphPad Prism 5 software to obtain the mean and standard deviation 
values of the Gaussian curve. Normal density function of Microsoft Excel was used to calculate 
the P values and to determine the -fold changes across the whole data set. Final protein 
quantitation ratios were determined by calculating the average value from the ratios of single 
measurements. Typical c-ICAT quantification accuracy using the above workflow was evaluated 
by using Bovine serum albumin standard at three different mixing ratios. Analytical coefficient 
of variation values was less than 10%. 
 
Prediction tools 
Secretion predictions were analyzed using the SignalP 3.023, SecretomeP 2.024 and SecretP25 
software. SignalP 3.0 and SecretomeP 2.0 were run at the Center of Biological Sequence 
analysis, publicly available prediction server http://www.cbs.dtu.dk/services/. SecretP was run at 
http://cic.scu.edu.cn/bioinformatics/secretp/index.htm. Functional annotation analysis was 
performed using the “Ingenuity Pathway Analysis” software. 
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Gene expression analysis 
Gene expression analysis was carried on 34 normal colon mucosa samples and 34 colon 
adenomas samples using the Affymetrix U133 Plus 2.0 platform as described in Sabates-Bellver 
et al.26 (GEO series record GSE8671). 
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Results and Discussion 
 
Secretome analysis of hT-RPE/MycER cells 
To investigate how the over-expression of the c-Myc oncoprotein could impact the 
secretome of non-transformed epithelial cells, we made use of hT-RPE/MycER cells, a human 
epithelial cell line immortalized with the catalytic subunit of Telomerase (hT-RPE) expressing a 
form of c-Myc (MycER) that can be activated by the addition of 4-hydroxytamoxifene (4-
OHT)11. Changes in the secretome induced by c-Myc were analyzed using a quantitative 
proteomic approach based on stable isotope labeling of proteins extracted from cell culture 
media of hT-RPE/MycER cells treated or not with 4-OHT. The experimental workflow used in 
this study is shown in Figure 1. 
Before replacing culture media with serum-free medium, we activated c-Myc with 4-OHT in 
the presence of FBS for 48 hours to ensure that the changes in the secretome induced by c-Myc 
were strong enough to be univocally defined. Serum-free culture media conditioned by hT-
RPE/MycER cells with or w/o 4-OHT were collected after 24 hours, concentrated and processed 
for proteomics and Western blot analysis. We have previously shown that activation of c-Myc in 
hT-RPE/MycER cells for 48 hours in serum-free medium results in the induction of apoptosis11. 
Given that under cell culture conditions cell lysis could be an end product of apoptosis, we 
investigated if c-Myc activation could lead to a cytosolic contamination of the culture media in 
the experimental setup of this study. Western blot analyses against two highly abundant cytosolic 
proteins (e.g. glyceraldehyde 3-phosphate dehydrogenase and actin) showed that culture media 
were not significantly contaminated by cytosolic proteins (at least in the range of sensitivity of 
this technique), neither in the presence nor in the absence of 4-OHT (Fig. 2). The same 
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conditioned media where instead highly positive for the presence of the secreted protease 
urokinase (uPA). The down-regulation of uPA in the experimental conditions used is in 
agreement with our previous findings11 and confirms that activation of c-Myc by 4-OHT is 
effective (Fig. 2). 
Stable isotope labeling by cleavable-Isotope Coded Affinity Tag (c-ICAT) technology has 
been shown to be particularly useful in secretome analyses27,28. In the present study we used 
second-generation c-ICAT containing an acid-cleavable linker and 13C (H = heavy) or 12C (L = 
light) isotopes to differentially label protein samples derived from hT-RPE/MycER cells treated 
or not with 4-OHT, respectively29-31 (2 independent experiments were performed). After labeling, 
the two samples of each experiment were combined and proteins were separated by 1-
dimensional SDS-PAGE (12% acrylamide), followed by Coomassie Brilliant Blue (R-250) 
staining. The entire gel lane was cut into 15 slices, and each of them was subjected to in-gel 
digestion, biotin affinity chromatography and nano-HPLC-ESI-MS/MS analysis, as described in 
the scheme presented in Fig. 1. The relative abundance of proteins was calculated using the 
MSQuant open source software22. This is illustrated in Supplementary Figure 1, which shows a 
typical mass spectrum of c-ICAT-labeled peptide pairs derived from the mixed inactive and 
active MycER samples. Details on the quantified peptides and proteins are listed in 
Supplementary Table 1. In this table the 125 unique proteins that were identified and quantified 
by MSQuant are reported. One hundred three (82%) of these proteins are predicted to be secreted 
by either classical and/or non classical secretion mechanisms according to SignalP23, SecP24 and 
SecretP25 in-silico secretome prediction analyses. Only 22 proteins (18%) are predicted to be 
either cytosolic or associated with the cytoskeleton (Supplementary Table 1). Finally, because in 
our previous microarray analysis of hT-RPE/Vec parental cells we found only few and slight 
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transcriptomic changes induced by 4-OHT treatment which were not overlapping with c-Myc-
induced changes11, we are confident that also most of the proteomic changes reported here are 
associated with the expression of c-Myc. 
Fig. 3A shows the normal distribution plotted in terms of the number of proteins as a 
function of binned log2 (active/inactive MycER) ratios. Non-linear regression analysis was 
performed to determine the mean values. The Gaussian ratio distribution curves of independent 
experiments are centered at the log2 ratio -1.3 (see also Supplementary Fig. 2). This negative 
deviation from zero indicates a significant leftward shift in data dispersion toward markedly 
lower H/L (i.e., c-Myc ON/c-Myc OFF) ratios and was attributed to a down-regulation of a large 
proportion of proteins in the secretome of c-Myc ON cells. The log2-transformed MycER 
active/inactive protein intensity ratios of the two independent c-ICAT experiments showed a 
good reproducibility of data obtained (Fig. 3B). Statistical analysis of the two biological 
replicates (Supplementary Tables) indicated that 2.5-fold or greater change in protein abundance 
of c-Myc active versus inactive cells could be considered biologically relevant and this was taken 
as a cut-off value.  
Using these criteria (i.e. 2.5<H/L<0.4), 49 proteins were found to be significantly down-
regulated and 12 significantly up-regulated following c-Myc activation (Table 1 and 2 
respectively). It is interesting to note that while 45 out of 49 down-regulated proteins are 
predicted to be secreted by the main signal peptide dependent mechanism (Table 1), up-regulated 
proteins are predicted to be secreted by non-classical mechanisms (6 out of 12) or not secreted (6 
out of 12) (Table 2). Secretory vesicles like exosomes were not depleted in the samples, and thus 
it is not surprising that some of the non-classically secreted extracellular proteins identified in 
this work (like filamin A, annexin 2 and actin) have been previously identified in exosome 
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samples and reported in the ExoCarta database. Western blot analysis of 6 of the 61 most 
significantly regulated proteins (CATD, TGFB2, IBP6, IBP7, DKK3 and vimentin) was 
performed on the conditioned media of hT-RPE/MycER cells treated or not treated with 4-OHT 
and is presented in Fig. 4. Western blot analysis confirmed that CATD, TGFB2, IBP6, IBP7 and 
DKK3 are down-regulated following c-Myc activation and that vimentin is up-regulated. 
As shown in Table 2, only 12 proteins were found to be significantly up-regulated by c-Myc 
(having an H/L >2.5). Six of them are predicted to be non-secreted proteins, and are therefore 
likely to be cytosolic contaminants of the samples. The remaining six proteins up-regulated by c-
Myc are predicted to be secreted by a non-classical secretion pathway. One of them, vimentin, is 
a well-known intermediate filament protein, but recent studies have shown that it is secreted by 
macrophages in response to pro-inflammatory signaling pathways32. Secreted soluble vimentin 
has been suggested to be a potential serological marker for small-size hepatocellular 
carcinoma33. Another c-Myc up-regulated protein, potentially secreted by a non-classical 
secretion pathway, is the translationally-controlled tumor protein (TCTP, 3-fold up-regulated), a 
protein over-expressed in cancer, with a putative anti-apoptotic activity34. Secretion of TCTP was 
shown to be facilitated by TSAP6, a p53-inducible protein35. Increased levels of TCTP in 
conditioned media of hT-RPE/MycER cells could therefore be mediated by the strong up-
regulation of p53 observed in this cellular system following c-Myc activation11. 
As mentioned above, almost all proteins down-regulated by c-Myc are predicted to be 
proteins secreted through the signal peptide dependent mechanism (Table 1). To have a general 
picture of the biological processes influenced by c-Myc activation, we analyzed the list of down-
regulated proteins using the Ingenuity Pathway Analysis platform. The analysis shows that 
“Cancer” is by far the disease process most significantly associated with the 49 proteins down-
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regulated upon c-Myc activation (Fig. 5A). This is interesting because the model system used in 
this work is not an established cancer cell line, but an immortalized epithelial cell line in which 
the process of oncogenic activation was mimicked by the expression of an activatable form of c-
Myc. The result of this analysis also shows that the top molecular and cellular functions 
associated with this set of proteins are: “Cellular Movement”, “Cellular Growth and 
Proliferation”, “Cell-To-Cell Signaling and Interaction” and “Cell Death” (Fig. 5B). Strikingly, 
these are the biological functions known to be regulated by c-Myc during oncogenic 
transformation10. We also performed a manual and extensive literature search for each of the 
down-regulated proteins presented in Table 1, to pinpoint the cellular function(s) that would be 
most affected by c-Myc activation. In line with results of the Ingenuity Pathway analysis, we 
found that about 25% of the proteins could be positively associated to growth inhibition and/or 
induction of cellular senescence, and an additional 25% of them could be associated with 
formation or modulation of the extracellular matrix (ECM). Both senescence and ECM 
interaction are believed to act as strong barriers to tumor progression36,37. The finding that c-Myc 
induces a marked reduction in secreted proteins belonging to these two functional categories, 
suggests that inhibition of cellular senescence and ECM remodeling may play a major role in 
early stage c-Myc induced oncogenesis. The proteins belonging to these two functional 
categories and their relevance to the process of oncogenic transformation are therefore discussed 
in more details. 
 
Secreted proteins with anti-proliferative/pro-senescence activity 
Cellular senescence is an irreversible cell cycle arrest triggered by telomere shortening as 
well as a variety of cellular stresses including the activation and/or inactivation of some 
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oncogenes38-40. Given that senescence acts as a potent barrier to tumor development, proteins 
mediating cellular senescence are expected to play important roles in tumorigenesis. Several 
secreted proteins have been proposed to contribute to the establishment of senescence8,41. Among 
them insulin-like growth factor (IGF) pathway related IGF-binding protein 6 (IBP6, with gene 
name IGFBP6) and 7 (IBP7, with gene name IGFBP7) for example play a significant role in 
senescence and can be considered as senescence markers. Both IGFBPs were shown to induce 
growth inhibition and senescence in melanocytes5,42, in neuroblastoma cells43 and in colorectal 
cancer44. IGFBP6 has been shown to be down-regulated by N-Myc in neuroblastoma cells43, 
epigenetically silenced in gastric cancer45 and strongly down-regulated in the secretome of 
ovarian cancer cell lines compared to normal epithelia46. In our analysis IGFBP6 and IGFBP7 
were found 7-fold and 5-fold down-regulated respectively upon c-Myc induction. 
The Wnt signaling pathway is known to play a major role in growth and proliferation during 
tumor development. Negative regulation of the Wnt pathway has been suggested to cause 
cellular senescence during the early stages of both colorectal tumors and melanomas7,47. 
Inhibition of Wnt signaling can be achieved either by the down-regulation of Wnt ligands, or by 
regulation of secreted Wnt inhibitors belonging to the Secreted Frizzled-Related Protein (SFRP) 
family and/or to the Dickkopf-related (DKK) family of proteins. Interestingly, we found both 
SFRP1 and DKK3 strongly down-regulated by c-Myc (10 and 4 fold changes, respectively), 
suggesting that c-Myc could have a positive effect on the activation of the Wnt pathway. SFRP1 
and the close homologue of DKK3, DKK1, have been shown to be transcriptionally repressed by 
c-Myc in breast cancer cells48. As a proof of the potential tumor suppressor role played by 
SFRP1 and DKK3, they were found epigenetically silenced in prostate cancer and their ectopic 
expression resulted in decreased proliferation49. DKK3 expression was found strongly reduced 
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also in malignant melanoma, but, in contrast to DKK1, its transcriptional repression did not 
involve promoter methylation, leaving space for transcription factors-mediated repression50. 
The TGFβ pathway has also been associated to inhibition of cell growth. c-Myc induced a 
marked down-regulation of TGFβ2 (TGFB2, 3.5-fold down regulated) (Table 1). The ability of 
c-Myc to bind Miz1 was shown to be important for the repression of TGFβ2 and to antagonize 
growth suppression and induction of senescence by TGFβ during lymphomagenesis6. Therefore, 
repression of TGFβ2 by c-Myc may be mediated by Miz1 and could play an important role in 
cancer progression. We also found a strong down-regulation of Follistatin-like protein 1 and 3. 
Although the function of these two proteins has not been univocally defined, FSTL1 was 
described to be positively modulated by TGFβ1 and to have tumor suppressor effects in human 
lung cancer cell lines51 and in ovarian and endometrial carcinogenesis52. 
Following c-Myc activation we also observed a strong down-regulation of some secreted 
proteases, like Cathepsins (CATB, 14.3-fold down regulated; CATD, 11-fold down-regulated; 
CATL1, 6-fold down-regulated) and Metalloproteases and their inhibitors (MMP2, 8-fold down-
regulated; TIMP2, 10-fold down-regulated; TIMP1, 4-fold down-regulated). Expression of both 
Metalloproteases and Cathepsins is known to increase during cancer progression, and to correlate 
to invasion and metastasis53. However, their expression was also found to correlate with the 
induction of senescence. Cathepsin D, for instance, has been proposed as promising marker of 
cellular senescence in several cancer cell lines treated with ionizing radiation54. Increased level 
of Cathepsin D was also observed during megakaryocytic maturation induced by thrombopoietin, 
a senescence-like cell-cycle arrest process55. The metalloprotease MMP2 and the metalloprotease 
inhibitor TIMP1 are also associated to senescence and are part of the Senescence-Associated 
Secretory Phenotypes signature both in human and mouse cells56. 
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Taken together, activation of c-Myc in hT-RPE/MycER cells induces a strong reduction in 
the conditioned media of proteins with a known or putative anti-proliferative/pro-senescence 
activity. Based on this observation, we analyzed culture media conditioned by hT-RPE/MycER 
cells with active or inactive c-Myc for their ability to sustain proliferation of parental hT-RPE, as 
a measure of autocrine effects of c-Myc activation. Cellular proliferation/viability was assessed 
measuring intracellular ATP content. The result is presented in Fig. 6A and shows that media 
conditioned by cells exposed to 4-OHT exhibit an increased ability to sustain 
proliferation/viability of hT-RPE cells, compared to control cells. It is tempting to speculate that 
the observed c-Myc ability to stimulate proliferation/viability in an autocrine manner could be 
mediated by the reduction in anti-proliferative proteins observed in our quantitative proteomic 
analysis. 
 
Secreted proteins associated to the ECM 
Twenty-five percent of the proteins down-regulated by c-Myc in our secretome study (Table 
1) are structurally or functionally associated to the extracellular matrix (ECM). Some of them are 
structural ECM or basement membrane (BM) proteins, like Biglycan (PGS1), Versican core 
protein (CSPG2), Laminin β (LAMB1) and Fibrillin-1 (FBN1) or cell surface molecules binding 
to the ECM or/and the BM, like Dystroglycan (DAG1) or Glypican-1 (GPC1). Others are 
supposed to be modulators of ECM function (ECM1, CCBE1, PXDN and CYR61). We also find 
down-regulated upon c-Myc activation the acetylglucosaminyltransferase responsible for glycan 
synthesis (B3GN1). Interestingly, B3GN1 was found down-regulated in prostate cancer resulting 
in a decreased interaction between epithelial cells and the BM57. c-Myc was already shown to 
repress the transcription of several genes controlling adhesion to the ECM58. Our data 
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complement this observation showing that also the soluble structural components of the ECM are 
regulated by c-Myc. The ECM has an extremely important role in epithelium development and 
tissue organization. Recognition and binding to the ECM by epithelial cells triggers survival 
signals and helps maintaining a differentiated status2,59. Therefore, reduction in ECM deposition 
by c-Myc expressing cells may be seen as a tissue remodeling event, potentially able to disrupt 
the normal tissue organization and start a new tissutal entity. Interestingly, structural 
rearrangements in ECM may also affect paracrine cellular signaling. It has been shown for 
instance that PGS1 can influence BMP4 morphogenetic gradients during early development60. 
ECM remodeling could affect tumor-stroma cross-talk also by creating a better substrate for 
stroma adhesion and a qualitative change in ECM could affect stroma recruitment by changing 
its chemoattractant ability. siRNA-mediated knockdown of the ECM protein CCBE1 in ovarian 
cancer cell lines was shown to enhanced cell migration. Accordingly CCBE1 was found 
frequently inactivated in ovarian cancer61. We found CCBE1 more than 6 times down-regulated 
by c-Myc in our secretome analysis (Table 1). 
Therefore, reduction in ECM deposition can be associated with a change in the chemotactic 
properties of the cells. We have previously reported that media conditioned by hT-RPE/MycER 
cells after c-Myc activation have a reduced chemotactic activity on parental hT-RPE cells11. We 
now asked whether the same media could influence cellular motility in a paracrine fashion, using 
mouse 3T3 fibroblasts as a surrogate of an abundant stroma cell type. Interestingly, as shown in 
Fig. 6B, we found that media conditioned by cells with c-Myc active showed an increased 
chemotactic potency towards 3T3 fibroblasts relative to media from cells with c-Myc inactive. 
Therefore, the secretome changes induced by c-Myc result in the increased ability to 
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chemoattract fibroblasts, suggesting that in vivo c-Myc over-expression may change the cross-
talk between tumor epithelial cells and fibroblast-like stroma cells.  
 
Gene expression analysis of c-Myc down-regulated proteins in colon adenoma specimens 
Since the functional annotation analysis shown in Fig. 7 suggests that the secretome changes 
we observed following c-Myc activation are relevant to cancer research, we sought to verify 
whether the 49 down-regulated factors identified in our analysis were also down-regulated in c-
Myc-over-expressing tumors. We took advantage of the transcriptomic analysis performed on 32 
samples of human colorectal adenomas and matched samples of normal mucosa from 28 patients 
described in Sabates-Bellver et al.26. The analysis is here extended to the transcriptome of 18 
established colorectal cancer (CRC) cell lines. As expected, in both adenomas and CRC cell lines 
there is a strong up-regulation of the gene coding for c-Myc (Supplementary Fig. 3). Of the 49 
genes coding for the proteins down-regulated by c-Myc in our secretome analysis, 41 were found 
expressed by the normal tissue and therefore further considered in the analysis. Twenty-seven of 
them (65%) were down-regulated at various degree in all the adenomas (Fig. 7 A, B); 24 genes 
(58%) were down-regulated at various degree in all the CRC cell lines (Fig. 7 A, B); 30 genes 
(73%) were down-regulated either in adenomas or in CRC cell lines (Fig. 7 A, B) and only 11 
(27%) were either not regulated or up-regulated in both adenomas and CRC cell lines (Fig. 7 C). 
Given that cancer cell lines are usually derived from invasive tumors, we postulate that the genes 
belonging to the second group (Fig 7 B) may have different roles during the course of cancer 
progression. It is worth noticing that TGFB2, a protein known to play a tumor suppressor role in 
early tumorigenesis and an oncogenic role in late tumorigenesis, belongs to this group. 
Therefore, the secretome analysis carried out with our epithelial cellular model of oncogenic 
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transformation let us identify a set of secreted factors that are likely to play crucial roles during 
early colorectal tumorigenesis, i.e., the adenomatous stage. 
 
Conclusions 
We performed a quantitative analysis of the secretome of epithelial cells in which the 
expression of c-Myc was induced. Being our cells non-transformed, this induction likely 
represents the only oncogenic event in these cells, mimicking therefore early stages of epithelial 
tumorigenesis. The expression of c-Myc was accompanied by a dramatic down-regulation of ~50 
proteins that appear to mediate autocrine and paracrine, anti-proliferative and pro-senescence 
effects. These findings are particularly interesting in the view of the fact that over-expression of 
c-Myc has been shown to be continuously required to release the tumorigenic barrier often 
operating in early tumor lesions. Also, numerous proteins associated to the ECM were down-
regulated by c-Myc, a finding that should be better explored to understand the effects of c-Myc 
expression on cell adhesion and motility. 
The relevance of our findings in the context of early tumor progression is supported by the 
observation that the expression of most of the factors identified in the secretome is markedly 
down-regulated also in colorectal adenomas, one of the most frequent preinvasive lesions 
detected in humans, and in which c-Myc is invariably overexpressed. We postulate that, in early 
stages of tumorigenesis, c-Myc sustains cell proliferation and overcomes senescence also by 
virtue of autocrine and paracrine mechanisms. This phenomenon, accompanied by ECM 
remodeling events, could favor the release of epithelial cells from the constraints given by the 
normal-tissue (i.e., colorectal mucosa) homeostasis and change the stromal microenvironment. 
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Fig. 1. Experimental workflow. The diagram shows how c-Myc was activated in hT-RPE-
MycER cells and how the exoprotein samples were prepared. After concentration, the samples 
were labeled with the c-ICAT reagent carrying either light (12C) or heavy (13C) carbon and 
resolved by SDS-PAGE. Proteins were subjected to in-gel proteolysis, affinity purification and 
the resulting peptides were identified and quantified through the steps indicated in the scheme. 
 
Fig. 2. Activation of c-Myc does not result in contamination of conditioned media with 
cytosolic proteins. hT-RPE-MycER cells were grown in 10% FBS +/- 4-OHT for 48 hours. They 
were then shifted to serum free medium for 24 hours in presence or absence of 4-OHT. Cells and 
conditioned media were collected and equal amounts of extracted proteins were analysed by 
Western blot for the presence of a known c-Myc-regulated secreted protein (uPA) and of two 
highly abundant cytosolic proteins, glyceraldehyde 3-phosphate dehydrogenase (GADPH) and 
actin. C.M.: conditioned media. 
 
Fig. 3. Statistical distribution of the c-ICAT data and reproducibility. (A) Normal Gaussian 
distribution curve fitted to experiment 1 data with mean value and standard deviation. The 
frequency distribution of log2 (active/inactive MycER) c-ICAT ratios was calculated and 
distributed into bins. The same analysis performed on experiment 2 is shown in Supplementary 
Fig. 2. (B) Comparison of the results of quantitative analysis of two biological samples. Scatter 
plot of log2-transformed cMycER active/inactive protein intensity ratios in two independent c-
ICAT analyses of two biological samples (experiment 1 and experiment 2). Each dot represents 
one of the 125 unique proteins identified. Dot line is a linear y=x trendline. 
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Fig. 4. Immunoblot analysis on some of the proteins most significantly regulated by c-Myc. 
Conditioned medium from hT-RPE/MycER cells grown in the absence or presence of 4-OHT 
was concentrated and 2 µg of total protein for each lane was loaded onto SDS-PAGE gels. 
Proteins were transferred onto PVDF and probed with the indicated primary antibodies. *: 
aspecific band. One representative of three independent experiments is shown. 
 
Fig. 5. Functional annotation analysis of c-Myc down-regulated extracellular proteins. The 
list of c-Myc down-regulated proteins shown in Table 1 was analyzed using the Ingenuity 
Pathway Analysis platform. Graphs A and B represent the statistical significance [indicated as –
Log(p-value)] of the enrichment of proteins belonging to the “Disease and Disorders” and 
“Molecular and Cellular Functions” categories respectively in the set of proteins analyzed. 
 
Fig. 6. c-Myc activation increases the ability of culture media to sustain 
proliferation/viability of hT-RPE cells and migration of 3T3 fibroblasts. hT-RPE-MycER 
cells were grown in 10% FBS for 48 hours and in serum free medium for 24 hours in absence 
(CM – 4-OHT) or presence (CM + 4-OHT) of 4-OHT. (A) Conditioned media were collected 
and used as culture media for parental hT-RPE. After 48 hours cellular proliferation/viability was 
measured using the Cell-Titer-Glo luminescent cell viability assay that measure the intracellular 
ATP level. The experiment was performed in triplicate and data are presented as percentage 
change relative to control (Cells treated with CM – 4-OHT). (B) Conditioned media were 
collected and used as chemoattractants in the lower compartment of Boyden chambers. Swiss-
3T3 mouse fibroblasts (1.5 x 105 cells/sample) were layered in the upper chamber and incubated 
for 2h at 37°C. Cell migration was quantified by counting the number of cells on the lower 
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chamber side of the filter. The experiment was performed in triplicate and data are presented as 
percentage change relative to control (migration against a solution of 0.1% BSA). Significance 
was calculated using the Student t test. The p-values for each experiment was < 0.001. 
 
Fig. 7. Secreted factors down-regulated by c-Myc are also down-regulated in colorectal 
adenomas and CRC cell lines. The expression of the genes coding for the proteins down-
regulated by c-Myc activation in conditioned media of hT-RPE/MycER cells was analyzed in 
microarray data sets (Affymetrix U133 Plus 2.0 platform) from 34 normal colon mucosa 
samples, 34 colon adenomas and 18 CRC cell lines (HCT116, CO115, SW48, GP5d, LS174T, 
SW620, HT29, Caco2, COLO741, SW837, SW480, CX-1, LS180, LS411, COLO205, SW403, 
LOVO, DLD1). Data are shown as % of the mean expression values in normal mucosa samples. 
(A) Genes down-regulated in both adenomas and in CRC cell lines; (B) genes down-regulated 
either in adenomas and or in CRC cell lines; (C) genes up-regulated in both adenomas and in cell 
lines. 
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Table 1. List of proteins down-regulated upon c-Myc activation. 
UniProt ID Protein UniProt Name Fold change
a
 Mass Secretion
b 
Exo
c
 
SFRP1_HUMAN Secreted frizzled-related protein 1 0.06 35386 Sec SP yes 
CATB_HUMAN Cathepsin B 0.07 37822 Sec SP yes 
SEM7A_HUMAN Semaphorin-7A 0.07 74824 Sec SP no 
CH3L1_HUMAN Chitinase-3-like protein 1 0.08 42625 Sec SP no 
APLP2_HUMAN Amyloid-like protein 2 0.08 86956 Sec SP yes 
ECM1_HUMAN Extracellular matrix protein 1 0.09 60674 Sec SP yes 
CATD_HUMAN Cathepsin D 0.09 44552 Sec SP yes 
SAP_HUMAN Proactivator polypeptide 0.09 58113 Sec SP yes 
TIMP2_HUMAN Metalloproteinase inhibitor 2 0.10 24399 Sec SP no 
GNS_HUMAN N-acetylglucosamine-6-sulfatase 0.10 62082 Sec SP no 
FSTL3_HUMAN Follistatin-related protein 3 0.11 27663 Sec SP no 
MMP2_HUMAN 72 kDa type IV collagenase 0.12 73882 Sec SP no 
MXRA8_HUMAN Matrix-remodeling-associated protein 8 0.13 49132 Sec SP yes 
FLNA_HUMAN Filamin-A 0.13 280739 NS yes 
IBP6_HUMAN Insulin-like growth factor-binding protein 6 0.14 25322 Sec SP no 
PTX3_HUMAN Pentraxin-related protein PTX3 0.15 42020 Sec SP yes 
CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 0.15 44103 Sec SP no 
GPC1_HUMAN Glypican-1 0.16 61650 Sec SP yes 
PGS1_HUMAN Biglycan 0.16 41628 Sec SP yes 
TICN1_HUMAN Testican-1 0.16 49124 Sec SP no 
CATL1_HUMAN Cathepsin L1 0.17 37564 Sec SP no 
PTPRB_HUMAN Receptor-type tyrosine-protein phosphatase beta 0.17 224188 Sec SP no 
UFO_HUMAN Tyrosine-protein kinase receptor UFO 0.18 98336 Sec SP no 
B3GN1_HUMAN N-acetyllactosaminide beta-1,3-N-
acetylglucosaminyltransferase 
0.19 47089 Sec SP no 
NPC2_HUMAN Epididymal secretory protein E1 0.19 16570 Sec SP no 
FBLN1_HUMAN Fibulin-1 0.20 77162 Sec SP yes 
SRCRL_HUMAN Scavenger receptor cysteine-rich domain-containing protein 0.20 115770 Sec SP no 
IBP7_HUMAN Insulin-like growth factor-binding protein 7 0.21 29130 Sec SP no 
CSPG2_HUMAN Versican core protein 0.21 372820 Sec SP no 
ANT3_HUMAN Antithrombin-III 0.23 52602 Sec SP no 
STC2_HUMAN Stanniocalcin-2 0.23 33249 Sec SP no 
ANXA2_HUMAN Annexin A2 0.24 38604 NCSec yes 
STC1_HUMAN Stanniocalcin-1 0.24 27621 Sec SP No 
TIMP1_HUMAN Metalloproteinase inhibitor 1 0.25 23171 Sec SP No 
DKK3_HUMAN Dickkopf-related protein 3 0.25 38291 Sec SP no 
LAMB1_HUMAN Laminin subunit beta-1 0.25 197937 Sec SP no 
OAF_HUMAN Out at first protein homolog 0.26 30669 Sec SP no 
PXDN_HUMAN Peroxidasin homolog 0.27 165170 Sec SP no 
DAG1_HUMAN Dystroglycan 0.28 97441 Sec SP yes 
FSTL1_HUMAN Follistatin-related protein 1 0.29 34986 Sec SP no 
TGFB2_HUMAN Transforming growth factor beta-2 0.29 47717 Sec SP no 
KPYM_HUMAN Pyruvate kinase isozymes M1/M2 0.30 57937 NS yes 
LIF_HUMAN Leukemia inhibitory factor 0.30 22008 Sec SP no 
ACTA_HUMAN Actin, aortic smooth muscle 0.31 42009 NCSec yes 
AGRIN_HUMAN Agrin 0.33 214846 Sec SP yes 
LMAN2_HUMAN Vesicular integral-membrane protein VIP36 0.33 40229 Sec SP no 
CYR61_HUMAN Protein CYR61 0.34 42027 Sec SP no 
FBN1_HUMAN Fibrillin-1 0.36 312298 Sec SP no 
CADH2_HUMAN Cadherin-2 0.37 99809 Sec SP no 
a
c-Myc ON/c-Myc OFF. 
b
Prediction results of secretion: Sec SP,classical secretion, NCSec, non classical 
secretion, NS non secreted. 
c
Present or not in exosomes preparations (ExoCarta database). 
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Table 2. List of proteins up-regulated upon c-Myc activation. 
UniProt ID Protein UniProt Name Fold change
a
 Mass Secretion
b
 Exo
c 
TALDO_HUMAN Transaldolase 2.49 37540 NS no 
HNRPD_HUMAN Heterogeneous nuclear ribonucleoprotein D0 2.61 38434 NS no 
NDKA_HUMAN Nucleoside diphosphate kinase A 2.63 17149 NS yes 
UCHL1_HUMAN Ubiquitin carboxyl-terminal hydrolase isozyme L1 2.66 24824 NCSec no 
PIN1_HUMAN Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 2.79 18243 NCSec no 
RS21_HUMAN 40S ribosomal protein S21 3.02 9111 NCSec yes 
RS3A_HUMAN 40S ribosomal protein S3a 3.17 29926 NCSec no 
TCTP_HUMAN Translationally-controlled tumor protein 3.25 19595 NCSec no 
FABP5_HUMAN Fatty acid-binding protein, epidermal 4.97 15164 NS no 
KI26A_HUMAN Kinesin-like protein KIF26A 6.22 194468 NS no 
VIME_HUMAN Vimentin 6.36 53652 NCSec no 
TARA_HUMAN TRIO and F-actin-binding protein 7.41 261217 NS no 
a
c-Myc ON/c-Myc OFF. 
b
Prediction results of secretion: Sec SP,classical secretion, NCSec, non classical 
secretion, NS non secreted. 
c
Present or not in exosomes preparations (ExoCarta database). 
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Table of Contents Synopsis 
We have applied a quantitative proteomics analysis to study changes in the secretome induced by 
the oncogene c-Myc. We found that c-Myc expression results in the down-regulation of proteins 
associated with growth inhibition and with the extracellular matrix. Strikingly, the expression of 
the majority of the proteins down-regulated by c-Myc, was significantly reduced also in 
colorectal adenomatous polyps, early tumors in which c-Myc is invariably over-expressed. 
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